Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Market Cap	$10.08B	P/E Ratio	12.13
52W High	$15.93	52W Low	$7.27
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-100.0%	52W Position	26.7%
Overall Score	45	Value Score	40
Quality Score	39	Technical Score	58

EPS Current Est	$0.79	EPS Next Est	$0.84
EPS Growth Est	+6.3%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AVTR	$9.58	+1.27%	8.04M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AVTR	$9.58	+1.3%	8.04M
3
4
5
6

AVTR

AVTR

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Avantor Inc. Data in Excel

Get Avantor Inc. Data in Excel